Access C- Peptide
- Risk class
- II
- Product type
- In Vitro Diagnostic
- Brand name
- Access
- Commercial name
- 19-126.- Reagents/Kits for IVD Assays, Immunoassay, Diabetes, C-Peptide
- Analysis ID
- 832ddb13bcf63f7433281c0cc9bcf737
- Registration date
- August 18, 2022
- Expiration date
- August 18, 2027
- City
- SUZHUO, P.R. CHINA
- Country
- CHINA
- Address
- 181 WEST SU HONG ROAD, SUZHUO INDUSTRIAL PARK, SUZHOU, P.R. CHINA, 215021
- Name
- BECKMAN COULTER, INC.
- Country
- UNITED STATES
- Address
- TODOS LOS SANTOS # 201 AND AV. JORGE PEREZ CONCHA
- Phone
- 2610680
THE C ACCESS PEPTIDE ASSAY IS A PARAMAGNETIC PARTICLE CHEMILUMINESCENCE IMMUNOASSAY FOR THE QUANTITATIVE DETERMINATION OF PEPTIDE C IN HUMAN SERUM, PLASMA OR URINE, FOR USE WITH HUMAN ACCESS IMMUNOASSAY AS AN AID TO DIAGNOSE PATIENTS WITH DIABETES OR SUSPECTED DIABETES AND OTHER DISORDERS IN INSULIN SECRETION
Access comprehensive regulatory information for Access C- Peptide in the Ecuador medical device market through Pure Global AI's free database. This II medical device is registered under ARCSA ID 832ddb13bcf63f7433281c0cc9bcf737 and manufactured by BECKMAN COULTER LABORATORY SYSTEMS (SUZHOU) CO., LDT. The device was registered on August 18, 2022.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.